Episode Details

Extremely effective vaccines from Pfizer and Moderna are on the way; both companies are preparing to seek FDA emergency use authorization. Accordingly, we have positioned our stock market portfolios for "bounce back" stocks. Today, we look deeper and reveal some unexpected beneficiaries of the vaccine news.